Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Cell Tissue Res. 2018 Mar 23;372(2):195–209. doi: 10.1007/s00441-018-2821-2

Figure 3. International Neuroblastoma Risk Group (INRG) Consensus Pretreatment Classification Schema.

Figure 3

Reprinted with permission. ©2009 American Society of Clinical Oncology. All rights reserved. Cohn, S et al: J Clin Oncol 27(2), 2009: 289–297. This is the original published INRG risk classification. All blank fields represent any value. GN, ganglioneuroma; GNB, ganglioneuroblastoma; Amp, amplified; NA, not amplified.